Latest Biotech News

Novel molecular biomarkers and approaches are emerging to enhance diagnostics and prognostics across oncology and neurology. Studies identify plasma microRNAs linked to peritoneal carcinomatosis...

Innovative engineering of stem cell sheets with aligned cellular structures enhances protein secretion, bolstering regenerative therapies for chronic and acute conditions. Studies also report...

Artificial intelligence integration significantly enhances diagnostic accuracy and adoption of novel technologies in medical practice. AI-assisted assessment improves pathologists’ interpretations...

Recent research highlights the multifaceted influence of climate change on health, ecosystems, and technology development. Studies explore the effects of global warming on infectious disease...

Cutting-edge research unravels complex mechanisms driving tumor progression and unveils novel therapeutic targets. Investigations reveal a transcription factor regulating bladder cancer via...

The biotech sector displays mixed financial activity with notable fundraising rounds and stock index rebounds after earlier declines. Field Medical secured $35 million in Series B venture capital...

The FDA has eliminated the Risk Evaluation and Mitigation Strategies (REMS) previously required for six approved CAR T cell therapies targeting BCMA and CD19 antigens, marking a significant shift...

The FDA granted accelerated approval to Dizal Pharmaceutical's oral drug sunvozertinib (Zegfrovy) for adults with locally advanced or metastatic non-small cell lung cancer harboring EGFR exon 20...

A team at Mie University in Japan has successfully used CRISPR-Cas9 technology to selectively remove the extra chromosome 21 responsible for Down syndrome in laboratory-grown human cells. This...

Google DeepMind introduced AlphaGenome, an AI foundation model that simultaneously predicts diverse genomic features such as gene expression, RNA splicing, chromatin accessibility, histone...

Recent research has provided compelling evidence for the continued generation of new neurons in adult human brains, settling longstanding scientific debate. Using advanced techniques, scientists...

Researchers have identified certain human gut bacterial strains capable of effectively sequestering perfluoroalkyl and polyfluoroalkyl substances (PFAS), commonly known as 'forever chemicals,'...

Led by University of Oxford Professor Jason Chin, the newly funded SynHG project aims to develop the technologies and methodology necessary to synthesize a complete human genome from scratch over...

A comprehensive meta-analysis published in Journal for Immunotherapy of Cancer demonstrates vaccination therapies' potential to improve outcomes in glioblastoma multiforme (GBM), an aggressive...

Thermo Fisher Scientific's Oncomine Dx Express Test, performed on the Ion Torrent Genexus Dx platform, received FDA approval as an in vitro diagnostic assay for the companion diagnostic use with...

The FDA has removed Risk Evaluation and Mitigation Strategies from several CAR T cell therapies, reducing regulatory requirements and facilitating broader use in clinical practice. Concurrently,...

The FDA has eliminated the Risk Evaluation and Mitigation Strategies (REMS) requirements for six approved CAR T cell therapies targeting BCMA and CD19 antigens, used in multiple myeloma and...

Dizal Pharmaceutical received accelerated FDA approval for sunvozertinib (Zegfrovy), its targeted oral therapy for non-small cell lung cancer with EGFR exon 20 insertion mutations in patients...

Scientists in Japan achieved a pioneering milestone by using CRISPR-Cas9 to selectively excise the third copy of chromosome 21 in human cells cultured in vitro, effectively removing the genetic...

A recent high-impact study leveraging innovative techniques unveils direct evidence of neural precursor cells and newborn neurons in adult human hippocampi, including in individuals up to age 78....